Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05727293
Other study ID # SYSKY-2022-469-01
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 6, 2022
Est. completion date November 6, 2022

Study information

Verified date September 2022
Source Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A case report of a patient with intellectual disability and neurogenic bladder complicated with sepsis


Description:

To summarize the individual care experience of a patient with neurogenic cystitis with sepsis and mental retardation. The main points of nursing care include: conducting personalized nuring care for early sepsis; carring out care for urinary incontinence and urinary tract infection; bulinding health-management plans with family members; and a full course of psychologic diversion that alleviates negative feelings among patients and family members.


Recruitment information / eligibility

Status Completed
Enrollment 1
Est. completion date November 6, 2022
Est. primary completion date October 10, 2022
Accepts healthy volunteers No
Gender Male
Age group N/A and older
Eligibility Inclusion Criteria: Dysgnosia Neurogenic bladder Pyohemia Exclusion Criteria: Intellectually normal person No urinary infection

Study Design


Intervention

Other:
noting
Non intervention

Locations

Country Name City State
China One Case of Individualized Nursing Plan for Sepsis Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Country where clinical trial is conducted

China, 

References & Publications (4)

Dinh A, Hallouin-Bernard MC, Davido B, Lemaignen A, Bouchand F, Duran C, Even A, Denys P, Perrouin-Verbe B, Sotto A, Lavigne JP, Bruyere F, Grall N, Tavernier E, Bernard L. Weekly Sequential Antibioprophylaxis for Recurrent Urinary Tract Infections Among — View Citation

von Gontard A, Hussong J, Yang SS, Chase J, Franco I, Wright A. Neurodevelopmental disorders and incontinence in children and adolescents: Attention-deficit/hyperactivity disorder, autism spectrum disorder, and intellectual disability-A consensus document — View Citation

Wehrberger C, Madersbacher S, Jungwirth S, Fischer P, Tragl KH. Lower urinary tract symptoms and urinary incontinence in a geriatric cohort - a population-based analysis. BJU Int. 2012 Nov;110(10):1516-21. doi: 10.1111/j.1464-410X.2012.11022.x. Epub 2012 — View Citation

Yang PY, Meng NH, Chou EC. Voiding dysfunctions in children with mental retardation. Neurourol Urodyn. 2010 Sep;29(7):1272-5. doi: 10.1002/nau.20824. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Lactic acid "In some pathological conditions, such as respiratory failure or circulatory failure, tissue hypoxia may be induced, and due to this hypoxia, lactic acid in the body may be elevated." Elevated lactic acid in the body can cause lactic acidosis. Checking the blood lactate level may indicate the severity of the underlying disease.The normal range is 0.05mmol/L-1.7mmol/L. During the first 6 days of ICU stay
Primary Sequential Organ Failure Assessment This scale can describe the dysfunction or failure of individual organs in a continuous form, and can evaluate the degree of mild dysfunction to severe failure. It can be used to measure the occurrence and development of single or whole organ dysfunction repeatedly in clinical research, so as to determine the characteristics describing organ dysfunction or failure, which has a closer relationship with sepsis. During the first 3 days of ICU stay
Primary Indicators of infection Hemameba level During the first 6 days of ICU stay
Primary C-reaction protein Indicators of infection During the first 6 days of ICU stay
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05361135 - 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia N/A
Not yet recruiting NCT06440304 - Therapeutic Options for CRAB Phase 4
Terminated NCT04250168 - Piloting Clinical Bacteriology in the Ebola Virus Disease Care Response
Recruiting NCT06018792 - Molecular Culture for the Diagnosis of Pediatric Sepsis
Completed NCT05246969 - Detecting Sepsis in Patients With Severe Subarachnoideal Hemorrhage
Recruiting NCT03782454 - Quantification of Bacterial DNA in Sepsis
Recruiting NCT06069206 - Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes N/A
Completed NCT05627076 - Analytical Validation of the abioSCOPE Device With the IVD CAPSULE PSP Test: Comparison of PSP Values Measured With Venous Whole Blood and Those Measured With Arterial Whole Blood.
Active, not recruiting NCT03617965 - Mortality Due to Septic Shock Associated With Thrombocytopenia
Active, not recruiting NCT04796285 - A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor N/A
Recruiting NCT04979767 - Function of Circulating Exosomes in Sepsis-induced Immunosuppression